These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 20472444)
21. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles. Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674 [TBL] [Abstract][Full Text] [Related]
22. Imaging and therapy of liver fibrosis using bioreducible polyethylenimine/siRNA complexes conjugated with N-acetylglucosamine as a targeting moiety. Kim SJ; Ise H; Kim E; Goto M; Akaike T; Chung BH Biomaterials; 2013 Sep; 34(27):6504-14. PubMed ID: 23726228 [TBL] [Abstract][Full Text] [Related]
23. Controlled delivery of plasmid DNA and siRNA to intracellular targets using ketalized polyethylenimine. Shim MS; Kwon YJ Biomacromolecules; 2008 Feb; 9(2):444-55. PubMed ID: 18186606 [TBL] [Abstract][Full Text] [Related]
24. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Merkel OM; Beyerle A; Librizzi D; Pfestroff A; Behr TM; Sproat B; Barth PJ; Kissel T Mol Pharm; 2009; 6(4):1246-60. PubMed ID: 19606864 [TBL] [Abstract][Full Text] [Related]
25. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603 [TBL] [Abstract][Full Text] [Related]
26. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome. Watanabe T; Umehara T; Yasui F; Nakagawa S; Yano J; Ohgi T; Sonoke S; Satoh K; Inoue K; Yoshiba M; Kohara M J Hepatol; 2007 Dec; 47(6):744-50. PubMed ID: 17822798 [TBL] [Abstract][Full Text] [Related]
28. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug. Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631 [TBL] [Abstract][Full Text] [Related]
29. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine. Alshamsan A; Haddadi A; Incani V; Samuel J; Lavasanifar A; Uludağ H Mol Pharm; 2009; 6(1):121-33. PubMed ID: 19053537 [TBL] [Abstract][Full Text] [Related]
30. Enhanced siRNA delivery using oleic acid derivative of polyethylenimine. Teng L; Xie J; Teng L; Lee RJ Anticancer Res; 2012 Apr; 32(4):1267-71. PubMed ID: 22493358 [TBL] [Abstract][Full Text] [Related]
31. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery. Wang XL; Xu R; Lu ZR J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104 [TBL] [Abstract][Full Text] [Related]
32. Prostate cancer cell-specific VEGF siRNA delivery system using cell targeting peptide conjugated polyplexes. Kim SH; Lee SH; Tian H; Chen X; Park TG J Drug Target; 2009 May; 17(4):311-7. PubMed ID: 19242850 [TBL] [Abstract][Full Text] [Related]
33. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. Murata N; Takashima Y; Toyoshima K; Yamamoto M; Okada H J Control Release; 2008 Mar; 126(3):246-54. PubMed ID: 18215787 [TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid-polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Jiang G; Park K; Kim J; Kim KS; Oh EJ; Kang H; Han SE; Oh YK; Park TG; Kwang Hahn S Biopolymers; 2008 Jul; 89(7):635-42. PubMed ID: 18322932 [TBL] [Abstract][Full Text] [Related]
35. Degradable polyethylenimines as DNA and small interfering RNA carriers. Jere D; Jiang HL; Arote R; Kim YK; Choi YJ; Cho MH; Akaike T; Cho CS Expert Opin Drug Deliv; 2009 Aug; 6(8):827-34. PubMed ID: 19558333 [TBL] [Abstract][Full Text] [Related]
36. Tyrosine-modified PEI: a novel and highly efficient vector for siRNA delivery in mammalian cells. Creusat G; Zuber G Nucleic Acids Symp Ser (Oxf); 2008; (52):91-2. PubMed ID: 18776268 [TBL] [Abstract][Full Text] [Related]
37. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Katas H; Cevher E; Alpar HO Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405 [TBL] [Abstract][Full Text] [Related]
38. Facial amphipathic deoxycholic acid-modified polyethyleneimine for efficient MMP-2 siRNA delivery in vascular smooth muscle cells. Kim D; Lee D; Jang YL; Chae SY; Choi D; Jeong JH; Kim SH Eur J Pharm Biopharm; 2012 May; 81(1):14-23. PubMed ID: 22311297 [TBL] [Abstract][Full Text] [Related]
39. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Kursa M; Walker GF; Roessler V; Ogris M; Roedl W; Kircheis R; Wagner E Bioconjug Chem; 2003; 14(1):222-31. PubMed ID: 12526712 [TBL] [Abstract][Full Text] [Related]
40. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Amarzguioui M; Peng Q; Wiiger MT; Vasovic V; Babaie E; Holen T; Nesland JM; Prydz H Clin Cancer Res; 2006 Jul; 12(13):4055-61. PubMed ID: 16818705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]